title: [Cobalt radioisotope teletherapy of patients with metastases to the brain].
abstract: The results are presented of palliative telecobaltotherapy in patients with metastases to the brain. The patients received a dose of 30 Gy in 10 fractions during 2 weeks. Clinical improvement was achieved in 28 out of 33 treated patients (85%). The survival time after the completion of radiotherapy was from 1 to 15 months, mean 5 months.
authors: Kliniki Radioterapii AM w Gdańsku.
authors: H
authors: H
authors: Karnicka-Młodkowska
authors: J
authors: J
authors: Jassem
authors: A
authors: A
authors: Dziewulska-Bokiniec
mesh_terms: D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D001943:Breast Neoplasms; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D003138:Common Bile Duct Neoplasms; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D008875:Middle Aged; D011867:Radioisotope Teletherapy
chemical_list: D003037:Cobalt Radioisotopes
vernacular_title: Telekobaltoterapia chorych z przerzutami do mozgu.